| Ansøgningsnr. og dato | 18802722.1 (espacenet) (Federated) (European Patent Register), 20180515 | | Patent/reg.nr. og dato | DK/EP 3624831, 20230329 | | Tilgængelighedsdato | 20200325 | | Prioritetsnr. og dato | US 201762506561 P, 20170515, US 201762506574 P, 20170515, US 201762506569 P, 20170515, US 201762529300 P, 20170706, US 201762564083 P, 20170927, US 201762567334 P, 20171003, US 201862618021 P, 20180116, US 201862624638 P, 20180131, US 201862660758 P, 20180420 | | EP publ. nr. og dato |
EP 3624831 20200325 | | Løbedag | | | Ansøger/indehaver | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | | Ansøgers ref. nr. | 1673379 | | Opfinder | DO, Hung, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
GOTSCHALL, Russell, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
KHANNA, Richie, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
LUN, Yi, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
CHAR, Hing, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
TESLER, Sergey, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
SUNDERLAND, Wendy, 1 Cedar Brook Drive
Cranbury
NJ 08512, US,
DILONÉ, Enrique, 1 Cedar Brook Drive
Cranbury
NJ 08512, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 38/43 (2006.01) , A61K 38/47 (2006.01) , A61P 21/00 (2006.01) , A61P 25/00 (2006.01) , A61P 43/00 (2006.01) | | Titel/benævnelse | REKOMBINANT HUMAN SUR ALFA-GLUCOSIDASE | | Internationalt ansøgningsnr. | US2018032815 | | Internationalt publ. nr. | WO2018213340 | | Relateret sag (certifikat) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
